There are a multitude of applications that call for a stable covalent linkage between two scientific biomolecules. While therapeutics can require antibody-drug conjugates, diagnostics rely on the labeling of proteins, antibodies, or antibody fragments with a method of detection. All such applications benefit from site-specific bioconjugation which does not interfere with the antigen binding site or the structural integrity of the antibody.

Biosynth's world-class linker technology CTAT™, takes advantage of the environmentally friendly, specific, and efficient properties of enzymes. From antibody-drug conjugates to stable, high-quality tools for diagnostics and industry, our enzyme linker technology produces site-specific, covalently conjugated molecules of your choice. Visit our enzyme technologies webpage for more information.

https://www.biosynth.com/biologics/enzymes/technologies#CTAT